- Isoform quantification is a bioinformatics process used to estimate the abundance of different transcript isoforms produced from the same gene. A single gene can generate multiple RNA transcripts through alternative splicing, alternative transcription start sites, alternative polyadenylation, and other RNA-processing mechanisms. These transcript variants are known as transcript isoforms. Although isoforms originate from the same gene, they may differ in exon composition, untranslated regions, coding sequences, and biological functions. Isoform quantification helps researchers understand how individual transcript variants are expressed across tissues, developmental stages, environmental conditions, and disease states.
- In eukaryotic organisms, genes are transcribed into precursor messenger RNA (pre-mRNA), which undergoes processing to produce mature RNA transcripts. During alternative splicing, different combinations of exons can be joined to generate multiple isoforms. Alternative promoter usage can produce transcripts with different 5′ ends, while alternative polyadenylation can generate transcripts with different 3′ ends. Some isoforms differ only in their untranslated regions, whereas others contain different protein-coding sequences. Consequently, the expression of a gene cannot always be adequately described by a single gene-level expression value. Isoform quantification provides a more detailed understanding of transcript-level gene expression.
- Transcript isoforms can have different biological consequences. Some encode proteins with altered amino acid sequences, while others produce proteins with different domains, cellular localization signals, or functional properties. Certain isoforms may contain premature termination codons and become targets of nonsense-mediated mRNA decay (NMD). Other transcripts may not encode proteins but may function as non-coding RNAs or participate in gene regulation. Changes in isoform abundance can therefore influence protein production, RNA stability, cellular differentiation, and biological pathways without necessarily producing a substantial change in total gene expression.
- RNA sequencing (RNA-seq) is one of the most widely used technologies for isoform quantification. In conventional short-read RNA-seq, RNA molecules are converted into complementary DNA (cDNA), fragmented, and sequenced into relatively short reads. These reads are mapped to a reference genome or transcriptome and assigned to known or reconstructed transcripts. However, because short reads often cover only a small part of a transcript, many reads cannot uniquely distinguish between highly similar isoforms. This creates an important computational challenge known as transcript ambiguity or multi-mapping. Isoform quantification algorithms address this problem by using read distribution, transcript structure, effective transcript length, and statistical models to estimate the abundance of individual isoforms.
- There are two major approaches to RNA-seq-based isoform quantification: alignment-based and alignment-free methods. Alignment-based approaches map sequencing reads to a reference genome or transcriptome before estimating transcript abundance. Tools such as RSEM, StringTie, and feature-aware quantification methods use read alignment information to estimate the expression of individual transcripts. Alignment-free or lightweight-alignment methods avoid traditional full genomic alignment and use sequence indexing and probabilistic assignment to quantify transcript abundance. Salmon and kallisto are widely used examples. These methods are computationally efficient and can process large RNA-seq datasets while accounting for uncertainty in assigning reads to similar transcripts.
- A typical isoform quantification workflow begins with RNA-seq quality assessment using FastQC and MultiQC. Adapter sequences and low-quality bases are removed using tools such as Cutadapt or fastp. A transcript reference is then selected from resources such as Ensembl, RefSeq, or GENCODE. In alignment-based workflows, reads are mapped using tools such as STAR or HISAT2, followed by transcript assembly or quantification using StringTie or RSEM. In lightweight-alignment workflows, Salmon or kallisto directly estimates transcript abundance using a transcriptome reference. The resulting abundance estimates can then be imported into R or Python for normalization, visualization, statistical comparison, and functional interpretation.
- Isoform abundance can be reported using several measurements. Transcript counts represent the estimated number of sequencing fragments assigned to a transcript, while normalized measurements account for differences in sequencing depth and transcript length. Transcripts per million (TPM) is a widely used measure for comparing relative transcript abundance within and across appropriately processed samples. It accounts for transcript length and the total abundance of all quantified transcripts in a sample.
- The basic calculation of TPM involves two steps. First, the estimated number of fragments assigned to a transcript is divided by its effective length to calculate reads or fragments per kilobase. Second, these values are scaled so that the sum of TPM values across all quantified transcripts in a sample equals one million.
- RPK = Estimated Fragment Count / Effective Transcript Length in Kilobases
- TPM = (RPK / Sum of RPK Values for All Transcripts) × 1,000,000
- Here, RPK represents fragments per kilobase, estimated fragment count represents the number of sequencing fragments assigned to a transcript, and effective transcript length accounts for the portion of the transcript available for fragment generation. TPM represents the relative abundance of a transcript after length and sample-level scaling. For paired-end RNA-seq, the corresponding fragment-based measure is commonly described as fragments per kilobase, rather than reads per kilobase. TPM values are useful for describing relative abundance, but they should not automatically be treated as raw counts for differential expression statistical models.
- Another important measurement is the relative contribution of an isoform to the total expression of its gene. This is often called the isoform fraction or transcript usage. It describes the proportion of a gene’s transcript abundance represented by a particular isoform.
- Isoform Fraction = Abundance of an Individual Isoform / Total Abundance of All Isoforms from the Gene
- Here, the numerator represents the estimated abundance of one transcript isoform, while the denominator represents the combined abundance of all quantified isoforms belonging to the same gene. When calculated from compatible abundance estimates, the fractions of all isoforms from a gene sum to approximately 1, or 100%. This measurement helps identify changes in transcript composition even when total gene expression remains relatively stable.
- Isoform quantification is different from gene-level expression analysis. Gene-level analysis combines the expression of all transcripts produced by a gene, whereas isoform-level analysis estimates the contribution of each individual transcript. For example, a gene may maintain similar total expression across two tissues while producing different transcript isoforms in each tissue. One tissue may predominantly express an isoform containing a particular exon, while another may express an isoform that lacks it. Such differences can reveal tissue-specific RNA processing and regulatory mechanisms that are not visible through conventional gene-level expression analysis.
- Differential transcript usage analysis investigates whether the relative abundance of isoforms from a gene changes between experimental conditions. Unlike differential gene expression, which focuses on changes in total gene expression, differential transcript usage examines changes in the proportions of different transcripts. Statistical approaches may use transcript counts, estimated abundance, and gene-level normalization to distinguish changes in isoform composition from changes in overall gene expression. Tools such as DRIMSeq, DEXSeq, satuRn, and IsoformSwitchAnalyzeR can support transcript usage and isoform-switching analyses. The selection of a method depends on the experimental design, quantification strategy, number of biological replicates, and research objective.
- Isoform switching occurs when the predominant transcript isoform of a gene changes between two or more biological conditions. For example, one transcript may be the most abundant isoform in healthy tissue, while another becomes dominant in diseased tissue. Such switches may change protein domains, coding potential, untranslated regions, or regulatory properties. IsoformSwitchAnalyzeR can help identify transcript switches and investigate their potential functional consequences, including changes in coding sequences, protein domains, signal peptides, and NMD sensitivity. However, predicted functional changes require appropriate biological interpretation and, where necessary, experimental validation.
- Short-read RNA-seq has limitations for accurately quantifying transcript isoforms. Similar transcripts may share most of their sequence, making it difficult to assign reads uniquely. Low-abundance isoforms may receive insufficient sequencing coverage, while incomplete or inaccurate transcript annotations can lead to incorrect abundance estimates. Alternative transcription start sites and polyadenylation sites can also complicate transcript identification. In addition, sequencing depth, read length, library preparation, RNA degradation, and sample composition influence quantification accuracy. Using biological replicates, high-quality reference annotations, appropriate normalization, and suitable statistical methods improves the reliability of the results.
- Long-read sequencing technologies, including Oxford Nanopore and PacBio sequencing, provide important advantages for isoform quantification. Long reads can span multiple exons and capture much larger portions of individual RNA molecules, making it easier to distinguish transcripts with complex exon structures. PacBio Iso-Seq and Oxford Nanopore direct RNA or cDNA sequencing can support the identification and quantification of full-length transcript isoforms. Tools such as FLAIR, StringTie2, TALON, and IsoQuant support long-read transcript identification, reconstruction, and quantification. However, long-read data also require careful correction of sequencing errors, transcript-end validation, and appropriate normalization.
- Functional interpretation is an important part of isoform quantification. Researchers may investigate whether changes in transcript abundance affect protein domains, cellular localization, signal peptides, binding sites, or biological pathways. Resources such as Ensembl, RefSeq, UniProt, InterPro, Gene Ontology (GO), KEGG, and Reactome support transcript and protein annotation. Integrating isoform-level expression with proteomics, ribosome profiling, and other molecular datasets can help determine whether changes in RNA abundance lead to corresponding changes in protein production and biological activity.
- Isoform quantification has important applications in disease research. Abnormal transcript isoform expression has been associated with cancer, neurological disorders, inherited diseases, immune dysfunction, and developmental abnormalities. In cancer, transcript switching may influence cell proliferation, apoptosis, metabolism, and tumor progression. In inherited disorders, alternative splicing may produce abnormal transcripts that encode dysfunctional proteins or are degraded through NMD. Isoform-level analysis can therefore identify disease-associated molecular changes and potential biomarkers that may not be detected through gene-level expression analysis.
- In animal genomics and breeding research, isoform quantification can help explain differences in gene regulation among breeds, tissues, developmental stages, and production environments. Researchers can investigate transcript isoforms associated with growth, muscle development, milk production, reproductive performance, feed efficiency, immune function, and disease resistance. For example, different isoforms of genes involved in muscle development may produce proteins with distinct structural or regulatory properties. Changes in transcript usage in mammary tissue may also provide information about molecular mechanisms associated with milk production and mammary function. Such findings can help identify candidate genes and regulatory mechanisms underlying economically important traits, although their value for genetic improvement requires validation through genetic and functional studies.
- Experimental validation is essential when important isoform differences are identified. Reverse transcription PCR (RT-PCR) can distinguish transcript variants using primers designed around specific exon combinations or transcript regions. Quantitative PCR (qPCR) with isoform-specific primers can measure relative transcript abundance. Sanger sequencing can confirm exon structures and splice junctions, while long-read sequencing can provide additional evidence about complete transcript structures. Northern blotting and proteomics may provide complementary information about transcript size and the corresponding protein products.
- Overall, isoform quantification is an essential component of transcriptomics because it provides information about the abundance and relative usage of individual RNA transcripts produced by a gene. RNA-seq, alignment-based and alignment-free quantification methods, transcript annotation, statistical analysis, and functional interpretation allow researchers to investigate transcript diversity and its biological consequences. Combining short-read and long-read sequencing with differential transcript usage analysis and experimental validation improves the understanding of alternative splicing, gene regulation, and transcript function. Isoform quantification is therefore important in functional genomics, disease research, molecular biology, and animal genomics, particularly when gene-level expression measurements alone cannot explain biological differences.